1. Home
  2. SLNO vs UGP Comparison

SLNO vs UGP Comparison

Compare SLNO & UGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • UGP
  • Stock Information
  • Founded
  • SLNO 1999
  • UGP 1937
  • Country
  • SLNO United States
  • UGP Brazil
  • Employees
  • SLNO N/A
  • UGP N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • UGP Oil/Gas Transmission
  • Sector
  • SLNO Health Care
  • UGP Utilities
  • Exchange
  • SLNO Nasdaq
  • UGP Nasdaq
  • Market Cap
  • SLNO 3.2B
  • UGP 3.4B
  • IPO Year
  • SLNO 2014
  • UGP 1999
  • Fundamental
  • Price
  • SLNO $74.47
  • UGP $2.89
  • Analyst Decision
  • SLNO Strong Buy
  • UGP Buy
  • Analyst Count
  • SLNO 9
  • UGP 3
  • Target Price
  • SLNO $103.33
  • UGP $4.10
  • AVG Volume (30 Days)
  • SLNO 744.8K
  • UGP 1.9M
  • Earning Date
  • SLNO 05-07-2025
  • UGP 05-07-2025
  • Dividend Yield
  • SLNO N/A
  • UGP 4.30%
  • EPS Growth
  • SLNO N/A
  • UGP N/A
  • EPS
  • SLNO N/A
  • UGP 0.35
  • Revenue
  • SLNO N/A
  • UGP $23,795,634,886.00
  • Revenue This Year
  • SLNO N/A
  • UGP $4.89
  • Revenue Next Year
  • SLNO N/A
  • UGP $1.95
  • P/E Ratio
  • SLNO N/A
  • UGP $7.76
  • Revenue Growth
  • SLNO N/A
  • UGP 8.37
  • 52 Week Low
  • SLNO $36.93
  • UGP $2.53
  • 52 Week High
  • SLNO $80.99
  • UGP $4.62
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 50.25
  • UGP 43.24
  • Support Level
  • SLNO $72.59
  • UGP $2.84
  • Resistance Level
  • SLNO $78.32
  • UGP $3.00
  • Average True Range (ATR)
  • SLNO 2.70
  • UGP 0.08
  • MACD
  • SLNO -0.63
  • UGP -0.02
  • Stochastic Oscillator
  • SLNO 32.52
  • UGP 15.15

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About UGP Ultrapar Participacoes S.A.

Ultrapar Participacoes SA engages in the investment of its own capital in services, commercial, and industrial activities, through the subscription or acquisition of shares of other companies. The Company has three business segments: Ultragaz distributes LPG in the segments: bulk, comprising condominiums, trade, services, industries, and agribusiness; and bottled, mainly comprising residential consumers. The Ipiranga engages in the distribution and sale of oil-related products, biofuels, and similar products to service stations that operate under the Ipiranga brand throughout Brazil and to consumers and carrier-reseller-retailer. The Ultracargo operates in specialized liquid bulk storage solutions in the main logistics centers of Brazil.

Share on Social Networks: